News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,277 Results
Type
Article (35139)
Company Profile (243)
Press Release (650885)
Multimedia
Podcasts (111)
Webinars (14)
Section
Business (218829)
Career Advice (846)
Deals (32999)
Drug Delivery (95)
Drug Development (74912)
Employer Resources (68)
FDA (15022)
Job Trends (12663)
News (318675)
Policy (25495)
Tag
2027 BioCapital Standard (2)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (10)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
40 Under 40 (1)
Academia (2168)
Academic (1)
Accelerated approval (57)
ADA (33)
Adcomms (19)
Allergies (181)
Alliances (49000)
ALS (220)
Alzheimer's disease (1562)
Antibody-drug conjugate (ADC) (637)
Approvals (15791)
Artificial intelligence (850)
ASCO (311)
Autoimmune disease (420)
Automation (73)
Bankruptcy (308)
Belgium (13)
Best Places to Work (10103)
BIO (58)
Biologics (41)
BIOSECURE Act (9)
Biosimilars (185)
BioSpace Insights (124)
Biotechnology (169)
Bispecific (13)
Bladder cancer (223)
Brain cancer (79)
Breast cancer (842)
Cancer (6903)
Cardiovascular disease (407)
Career advice (737)
Career pathing (19)
CAR-T (422)
CDC (16)
CDMO (152)
Celiac Disease (4)
Cell-line development (2)
Cell therapy (1166)
Cervical cancer (55)
Clinical research (66382)
Collaboration (2416)
Commercialization (26)
Company closure (5)
Compensation (1691)
Complete response letters (67)
COVID-19 (1994)
CRISPR (131)
CRO (1)
C-suite (1352)
Cystic fibrosis (160)
Data (9044)
Decentralized trials (3)
Denatured (37)
Depression (137)
Dermatology (126)
Diabetes (572)
Diagnostics (6896)
Digital health (70)
Diversity (7)
Diversity, equity & inclusion (14)
Drug discovery (402)
Drug pricing (46)
Drug shortages (8)
Duchenne muscular dystrophy (279)
Earnings (86947)
Editorial (29)
Employer branding (9)
Employer resources (64)
Events (115383)
Executive appointments (1135)
Eye disease (5)
FDA (19326)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (34)
Funding (1885)
Gene editing (279)
Generative AI (68)
Gene therapy (812)
GLP-1 (641)
Government (2374)
Grass and pollen (4)
Guidances (378)
Healthcare (15728)
Hematology (185)
HIV (92)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (113)
Immunology and inflammation (267)
Immuno-oncology (130)
Indications (243)
Infectious disease (2314)
Inflammatory bowel disease (205)
Inflation Reduction Act (8)
Influenza (135)
Intellectual property (343)
Interviews (121)
IPO (15478)
IRA (12)
Job creations (2944)
Job search strategy (644)
JPM (42)
Kidney cancer (28)
Kidney disease (93)
Labor market (44)
Layoffs (327)
Leadership (14)
Legal (6282)
Licensing (46)
Liver cancer (104)
Longevity (40)
Lung cancer (1010)
Lung diease (11)
Lymphoma (526)
Machine learning (69)
Management (25)
Manufacturing (1219)
Marketing (15)
MASH (167)
Medical affairs (2)
Medical device (13889)
Medtech (14170)
Mergers & acquisitions (18903)
Metabolic disorders (1186)
mRNA (269)
Multiple sclerosis (207)
Multispecific (3)
NASH (9)
Netherlands (11)
Neurodegenerative disease (444)
Neuropsychiatric disorders (62)
Neuroscience (3100)
Neurotech (1)
NextGen: Class of 2026 (5399)
Non-profit (2494)
Now hiring (36)
Obesity (414)
Opinion (174)
Ovarian cancer (262)
Pain (250)
Pancreatic cancer (380)
Parkinson's disease (387)
Partnered (33)
Patents (693)
Patient advocacy (1)
Patient recruitment (860)
Patient selection (40)
Peanut (65)
People (55612)
Peptides (17)
Pharmaceutical (46)
Pharmacy benefit managers (15)
Phase 1 (21891)
Phase 2 (29469)
Phase 3 (20805)
Pipeline (11580)
Policy (123)
Postmarket research (2039)
Preclinical (9692)
Press Release (72)
Prostate cancer (330)
Psychedelics (28)
Radioligand (1)
Radiopharmaceuticals (369)
Rare diseases (1138)
Real estate (5171)
Recruiting (29)
Regenerative medicine (13)
Regulatory (22500)
Reports (38)
Research institute (2122)
Resumes & cover letters (136)
Rett syndrome (51)
RNA editing (26)
RSV (71)
Schizophrenia (141)
Series A (340)
Series B (229)
Service/supplier (6)
Sickle cell disease (141)
Special edition (11)
Spinal muscular atrophy (153)
Sponsored (41)
Startups (3530)
State (2)
Stem cells (1)
Stomach cancer (18)
Substance use disorders (17)
Supply chain (95)
Switzerland (1)
Tariffs (24)
The Weekly (71)
Vaccines (877)
Venture capital (90)
Weight loss (169)
Wet AMD (2)
Women's health (130)
Worklife (5)
Date
Today (49)
Last 7 days (596)
Last 30 days (2136)
Last 365 days (28124)
2026 (21759)
2025 (27709)
2024 (32683)
2023 (37398)
2022 (48231)
2021 (51876)
2020 (48568)
2019 (39002)
2018 (29339)
2017 (29389)
2016 (28397)
2015 (34856)
2014 (29390)
2013 (25397)
2012 (27299)
2011 (27582)
2010 (26236)
Location
Africa (517)
Alabama (103)
Alaska (7)
Arizona (394)
Arkansas (17)
Asia (37707)
Australia (6195)
California (15159)
Canada (4182)
China (1562)
Colorado (643)
Connecticut (611)
Delaware (398)
Europe (76263)
Florida (2260)
Georgia (474)
Hawaii (4)
Idaho (62)
Illinois (1155)
India (100)
Indiana (513)
Iowa (29)
Japan (681)
Kansas (140)
Kentucky (57)
Louisiana (43)
Maine (94)
Maryland (1680)
Massachusetts (10886)
Michigan (425)
Minnesota (816)
Mississippi (6)
Missouri (156)
Montana (32)
Nebraska (21)
Nevada (155)
New Hampshire (91)
New Jersey (3665)
New Mexico (33)
New York (3838)
North Carolina (1837)
North Dakota (12)
Northern California (7692)
Ohio (445)
Oklahoma (26)
Oregon (33)
Pennsylvania (2925)
Puerto Rico (31)
Rhode Island (55)
South America (800)
South Carolina (96)
South Dakota (1)
Southern California (6148)
Tennessee (222)
Texas (2547)
United States (52393)
Utah (456)
Vermont (2)
Virginia (315)
Washington D.C. (59)
Washington State (1209)
West Virginia (3)
Wisconsin (165)
Wyoming (2)
686,277 Results for "stemedica cell technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
BMS ends Cellares pact over cell therapy production problems, triggering layoffs
Setbacks to efforts to use Cellares’ automated platform to make an approved CAR-T cell therapy led BMS to terminate its partnership with the manufacturing specialist.
August 26, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
MUSE Cells Now Available at Longevity Medical Institute®
As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.
September 18, 2026
·
1 min read
Press Releases
Cellares and GenomeFrontier Therapeutics Partner to Evaluate Automated Manufacturing for GF-CART01 on the Cell Shuttle® Platform
September 16, 2026
·
6 min read
Sponsored by Sino Biological
Unlocking cell surface protein research with site-specific labeling
Applications in flow cytometry, cell sorting, target validation, and therapeutic discovery
September 14, 2026
·
8 min read
IN PARTNERSHIP WITH LONGEVITY MEDICAL INSTITUTE
Regenerative medicine needs more than stem cells
Stem cell therapies vary widely yet many physicians still treat them as interchangeable. A more credible model requires diagnostics, product characterization and conventional medical context to determine who and when should receive regenerative treatment.
September 28, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Press Releases
Cryopraxis, BioNK and Radboudumc Partner to Transfer Cord Blood-Derived NK Cell Technology to Brazil
September 2, 2026
·
1 min read
Press Releases
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
June 22, 2026
·
7 min read
Sponsored by AGC Biologics
Beyond Random Integration: Transposase cell line development shortening timeline & boosting titers
As molecule complexity rises, advanced cell line development platforms are giving biopharma companies new tools to overcome expression challenges, improve stability and reach the clinic faster.
September 21, 2026
·
7 min read
·
AGC Biologics
Press Releases
Cellares and Sonoma Biotherapeutics Collaborate to Automate Manufacturing of SBT-77-7101 Engineered Treg Cell Therapy on the Cell Shuttle® Platform
July 13, 2026
·
5 min read
Opinion
Blood centers can help biopharma scale cell and gene therapies
Blood centers have the donors, resources and community footprint drug sponsors need to solve supply chain issues around cell and gene therapies.
September 15, 2026
·
6 min read
·
Becky Cap
1 of 68,628
Next